세계의 마이크로바이옴 시퀀스 서비스 시장

Global Microbiome Sequencing Services Market to Reach US$5.5 Billion by 2030

The global market for Microbiome Sequencing Services estimated at US$1.7 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 18.1% over the analysis period 2023-2030. Synthesis Technique, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Ligation Technique segment is estimated at 14.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$476.2 Million While China is Forecast to Grow at 17.3% CAGR

The Microbiome Sequencing Services market in the U.S. is estimated at US$476.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$842.1 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.8% and 15.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Microbiome Sequencing Services Market - Key Trends & Drivers Summarized

What Are Microbiome Sequencing Services, and Why Are They So Crucial in Modern Genomics and Healthcare?

Microbiome Sequencing Services involve the use of advanced sequencing technologies to analyze and characterize the microbial communities found in various environments, including the human body, soil, water, and plants. These services provide detailed insights into the composition, diversity, and function of microbiomes, which consist of bacteria, viruses, fungi, and other microorganisms. Technologies like 16S rRNA sequencing, shotgun metagenomics, and whole-genome sequencing are used to decode the genetic material of microbes, uncovering their roles in health, disease, agriculture, and the environment.

The importance of microbiome sequencing lies in its ability to reveal the critical roles that microbes play in human health, disease prevention, nutrition, agriculture, and ecological balance. In healthcare, microbiome analysis has paved the way for personalized medicine, enabling the development of targeted therapies for conditions like gastrointestinal diseases, metabolic disorders, autoimmune diseases, and even mental health conditions. In agriculture, it helps improve soil health, crop yield, and plant disease resistance. As the understanding of microbiomes advances, microbiome sequencing services are becoming essential tools in both clinical research and environmental management.

How Are Technological Advancements Shaping the Microbiome Sequencing Services Market?

Technological advancements have significantly enhanced the accuracy, speed, and cost-effectiveness of Microbiome Sequencing Services, driving innovation across healthcare, agriculture, and environmental sciences. One of the major developments is the adoption of next-generation sequencing (NGS) platforms, which offer high-throughput, rapid sequencing capabilities at a lower cost. NGS technologies, including Illumina sequencing, Oxford Nanopore sequencing, and PacBio sequencing, provide detailed insights into microbial diversity and function, enabling more comprehensive analysis of complex microbiomes. This has expanded the use of microbiome sequencing in personalized medicine, drug development, and diagnostics.

The rise of shotgun metagenomics has further improved the capabilities of microbiome sequencing services. Unlike targeted 16S rRNA sequencing, shotgun metagenomics sequences all genetic material in a sample, allowing for a more detailed view of microbial composition, including both known and novel species. It also provides functional insights, such as microbial metabolic pathways and gene expression profiles, which are crucial for understanding how microbiomes influence health, disease, and ecological balance. This technology has been instrumental in uncovering microbial roles in immune modulation, nutrient absorption, and drug metabolism, supporting both clinical research and therapeutic development.

Advancements in bioinformatics and data analytics have also played a key role in shaping the microbiome sequencing market. Powerful bioinformatics tools and machine learning algorithms now enable researchers to process large volumes of sequencing data, identify microbial taxa, predict functional pathways, and correlate microbiome profiles with specific health conditions or environmental parameters. This has improved the interpretation of complex microbiome data, making sequencing services more actionable and valuable for clinical, agricultural, and ecological applications. Additionally, the development of cloud-based platforms has facilitated the sharing, storage, and analysis of microbiome data, enabling global collaboration and more efficient research. These technological innovations not only expand the capabilities of microbiome sequencing services but also align with broader trends toward precision medicine, sustainable agriculture, and environmental monitoring.

What Are the Emerging Applications of Microbiome Sequencing Services Across Different Sectors?

Microbiome Sequencing Services are finding expanding applications across various sectors, driven by the need for deeper insights into microbial roles in health, disease, agriculture, and environmental sustainability. In the healthcare sector, microbiome sequencing is used to study the human microbiome, particularly in the gut, skin, oral cavity, and respiratory tract. It enables the development of personalized treatments for conditions like irritable bowel syndrome (IBS), obesity, diabetes, and inflammatory bowel disease (IBD). Sequencing the gut microbiome helps identify beneficial bacteria that can be targeted with probiotics, prebiotics, and dietary interventions, supporting personalized nutrition and gut health management.

In the pharmaceutical industry, microbiome sequencing is used in drug discovery and development. By analyzing how microbiomes influence drug metabolism and patient response, pharmaceutical companies can develop more targeted therapies and reduce adverse drug reactions. This approach is particularly valuable in the development of microbiome-based therapeutics, which use live bacteria or microbial metabolites to treat conditions like Clostridioides difficile infection, ulcerative colitis, and atopic dermatitis. Microbiome sequencing also supports the development of vaccines by identifying microbial components that can be used as antigens, contributing to infectious disease prevention.

In the agriculture sector, microbiome sequencing is used to enhance crop yield, improve soil health, and develop biocontrol agents for plant diseases. It helps identify beneficial soil microbes that promote nutrient absorption, enhance plant growth, and suppress pathogenic organisms. Sequencing services enable the creation of microbial consortia, which are added to soil or seeds to improve crop performance and resilience, supporting sustainable farming practices. In the environmental sector, microbiome sequencing aids in bioremediation efforts, where microbes are used to break down pollutants in soil and water. It also supports ecosystem monitoring by analyzing changes in microbial diversity due to factors like pollution, climate change, and habitat destruction. The expanding applications of microbiome sequencing across these sectors highlight its critical role in driving innovation, improving outcomes, and supporting sustainability in both human health and the environment.

What Drives Growth in the Microbiome Sequencing Services Market?

The growth in the Microbiome Sequencing Services market is driven by several factors, including increasing demand for personalized medicine, rising investments in microbiome research, and technological advancements in sequencing. One of the primary growth drivers is the growing interest in the human microbiome and its impact on health and disease. As research continues to uncover links between microbiome composition and various health conditions, there is increasing demand for microbiome sequencing in both clinical and research settings. This demand is particularly strong in areas like gut health, where microbiome-targeted therapies and diagnostics are becoming mainstream in precision medicine.

Rising investments in microbiome research have further fueled demand for sequencing services. Governments, pharmaceutical companies, and biotechnology firms are investing heavily in microbiome projects, supporting the development of new drugs, probiotics, and diagnostic tools. In addition, public health initiatives focusing on antimicrobial resistance, gut health, and metabolic disorders have led to increased funding for microbiome studies, boosting demand for sequencing services that provide detailed microbial insights.

Advancements in sequencing technologies and bioinformatics have also contributed to market growth. The development of high-throughput, cost-effective sequencing platforms has made microbiome sequencing more accessible to researchers, healthcare providers, and agritech firms. Improved bioinformatics tools have enhanced the interpretation of complex microbiome data, making it easier to translate sequencing results into actionable insights for clinical, agricultural, and environmental applications. Additionally, the rise of direct-to-consumer microbiome testing has increased public awareness and interest in personal microbiome analysis, supporting market growth in consumer health and wellness.

With ongoing innovations in sequencing, data analytics, and microbiome-based therapeutics, the microbiome sequencing services market is poised for robust growth. These trends, combined with increasing demand for precision medicine, sustainable agriculture, and environmental monitoring, make microbiome sequencing a vital component of modern scientific and clinical strategies focused on improving human health, enhancing agricultural productivity, and supporting ecological balance across various sectors.

SCOPE OF STUDY:

The report analyzes the Microbiome Sequencing Services market in terms of US$ Thousand by the following End-Use; Technique, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceutical, Academic & Research Institutes, Biotech); Technique (Synthesis, Ligation, Pyrosequencing, Sanger Sequencing, Other Techniques)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

• AnimalBiome
• Arranta Bio
• BIOHM
• Biom Pharmaceutical Corporation
• BioMathematica
• BiomeSense
• Biomesight
• BIOMx
• Biose Industry
• Biotage AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Microbiome Sequencing Services - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Research on Gut Health Sets the Stage for Microbiome Analysis
  • Rising Incidences of Chronic Diseases Spur Demand for Microbiome Sequencing
  • Expanding Use in Cancer Research Generates Market Opportunities
  • Enhanced Accuracy and Speed of Sequencing Drives Adoption in Healthcare
  • Strong Investment in Genomics Research Crucial for Market Growth
  • Use in Drug Development Expands Microbiome Sequencing Market
  • Rising Demand for Functional Foods and Probiotics Propels Sequencing Adoption
  • Integration with AI for Predictive Analysis Strengthens Business Case
  • Expanding Applications in Dermatology Generate Demand for Sequencing Services
  • Growing Interest in Gut-Brain Axis Research Fuels Microbiome Sequencing Demand
  • Increasing Use in Nutrigenomics Generates Market Opportunities
  • Expanding Role in Infectious Disease Research Drives Sequencing Adoption
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Microbiome Sequencing Services Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World 7-Year Perspective for Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Ligation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 7: World 7-Year Perspective for Ligation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pyrosequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World 7-Year Perspective for Pyrosequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Sanger Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World 7-Year Perspective for Sanger Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 13: World 7-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 15: World 7-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 17: World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 19: World 7-Year Perspective for Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 22: USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: USA 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• CANADA
  • TABLE 24: Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: Canada 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Canada 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• JAPAN
  • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 28: Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Japan 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 30: Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 31: Japan 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• CHINA
  • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 32: China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: China 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 34: China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 35: China 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• EUROPE
  • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 36: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 37: Europe 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 38: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 40: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 41: Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• FRANCE
  • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 42: France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 43: France 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 44: France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: France 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• GERMANY
  • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 46: Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 47: Germany 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 48: Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 49: Germany 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• ITALY
  • TABLE 50: Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Italy 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 52: Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 53: Italy 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• UNITED KINGDOM
  • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 54: UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 55: UK 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 56: UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: UK 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• REST OF EUROPE
  • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 59: Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 61: Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• ASIA-PACIFIC
  • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 65: Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
• REST OF WORLD
  • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 67: Rest of World 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
  • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Rest of World 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030

IV. COMPETITION